# DECORPORATION MCM PHASE 1 CLINICAL SAFETY STUDY

> **NIH NIH N01** · SRI INTERNATIONAL · 2024 · $2,898,062

## Abstract

This contract provides support services to develop a product against injuries resulting from radiation exposure to include development of and testing of medical countermeasures in animal models of radiation injury, as well as provision of samples for biodosimetry studies

## Key facts

- **NIH application ID:** 11041810
- **Project number:** 75N93020D00011-P00005-759302100001-1
- **Recipient organization:** SRI INTERNATIONAL
- **Principal Investigator:** POLLY Yee CHANG
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $2,898,062
- **Award type:** —
- **Project period:** 2021-09-01 → 2025-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11041810

## Citation

> US National Institutes of Health, RePORTER application 11041810, DECORPORATION MCM PHASE 1 CLINICAL SAFETY STUDY (75N93020D00011-P00005-759302100001-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/11041810. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*